Exhibit 4.4

  

  

  

  
    WARRANT AGREEMENT

    

    

    between

    

    

    LONGVIEW ACQUISITION CORP. II

    

    

    and

    

    

    CONTINENTAL STOCK TRANSFER & TRUST COMPANY

    

    

    THIS WARRANT AGREEMENT (this “Agreement”), dated as of [●], 2021, is by and between Longview Acquisition Corp. II, a Delaware corporation (the “Company”), and Continental Stock Transfer
      & Trust Company, a New York limited purpose trust company, as warrant agent (in such capacity, the “Warrant Agent”; also referred to herein as the “Transfer Agent”).

    

    

    WHEREAS, the Company has entered into that certain Private Placement Warrants Purchase Agreement with Longview Investors II LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor agreed to
      purchase an aggregate of 8,000,000 warrants (or 9,000,000 warrants in the aggregate if the Over-allotment Option (as defined below) in connection with the Company’s Offering (as defined
      below) is exercised in full) simultaneously with the closing of the Offering (and the closing of the Over-allotment Option, if applicable) bearing the legend set forth in Exhibit B
      hereto (the “Private Placement Warrants”) at a purchase price of $1.50 per Private Placement Warrant;

    

    

    WHEREAS, the Company has entered into that certain Forward Purchase Agreement (the “Forward Purchase Agreement”)
      with funds affiliated with Glenview Capital Management, LLC (collectively, the “Glenview Funds”), pursuant to which the Glenview Funds will be
      issued redeemable warrants (the “Forward Purchase Warrants”) in a private placement transaction to occur at or prior to the time of the Company’s
      initial Business Combination (as defined below);

    

    

    WHEREAS, in order to finance the Company’s transaction costs in connection with an intended initial Business Combination (as defined below), the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers
      and directors may loan the Company funds as the Company may require, of which up to $2,000,000 of such loans may be converted into up to an additional 1,333,333 Private Placement Warrants at a
        price of $1.50 per warrant at the option of the lender (the “Working Capital
        Warrants”);

    

    

    WHEREAS, the Company is engaged in an initial public offering (the “Offering”) of units of the Company’s equity securities, each such unit comprised of one
      share of Common Stock (as defined below) and one-fifth of one Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined to issue and deliver up to 10,000,000 redeemable warrants (or up to 11,500,000 redeemable warrants to
      the extent the Over-allotment Option is exercised) to public investors in the Offering (the “Public Warrants”). Each whole Warrant entitles the holder thereof to purchase one share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), for
      $11.50 per whole share, subject to adjustment as described herein. Only whole Warrants are exercisable. A holder of the Public Warrants will not be able to exercise any fraction of a Warrant;

    

    

    
      
        


    

    
    WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1, No. 333-252594 (the “Registration Statement”), and prospectus (the “Prospectus”), for the registration, under the
      Securities Act of 1933, as amended (the “Securities Act”), of the Units, the Public Warrants and the Common Stock included in the Units and the Common Stock included in the Public Warrants;

    

    

    WHEREAS, following the consummation of the Offering, the Company may issue additional warrants (“Post-IPO Warrants”
      and, together with the Private Placement Warrants, the Forward Purchase Warrants, the Working Capital Warrants and the Public Warrants, the “Warrants”)







      in connection with, or following the consummation by the Company of, a Business Combination;

    

    

    WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of
      the Warrants;

    

    

    WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the
      Company, the Warrant Agent and the holders of the Warrants; and

    

    

    WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent (if a physical certificate
      is issued), as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.

    

    

    NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

    
      

      

      1.           Appointment of Warrant Agent.
          The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this
          Agreement.

       

      

      2.           Warrants.

       

      

      2.1.          Form of Warrant. Each Warrant shall initially be issued in registered form only.

        

      

      2.2.          Effect of
              Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant certificate shall be invalid and of no effect and may not be exercised by the holder
          thereof.

       

      

      
        -2-

        
          


      

      2.3.          Registration.

       

      

      2.3.1.      Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”) for the registration of original issuance and the
        registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with
        instructions delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially be represented by one or more Book-Entry Warrant Certificates deposited with The Depository Trust Company (the “Depositary”) and registered in the name of Cede & Co., a nominee of the Depositary. Ownership of beneficial interests in the Public Warrants shall be shown on, and the transfer of such ownership shall be effected
        through, records maintained by (i) the Depositary or its nominee for each Book-Entry Warrant Certificate, or (ii) institutions that have accounts with the Depositary (each such institution, with respect to a Warrant in its account, a “Participant”).

      

      If the Depositary subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding
        making other arrangements for book-entry settlement. In its sole discretion, the Company may instruct the Warrant Agent to deliver to the Depositary (i) written instructions to deliver to the Warrant Agent for cancellation each book-entry Public
        Warrant and (ii) definitive certificates in physical form evidencing such Warrants (“Definitive Warrant Certificates”), which shall be in the
        form annexed hereto as Exhibit A.

       

      

      Physical certificates, if issued, shall be signed by, or bear the facsimile signature of, the Chairman of the Board, Chief Executive Officer, Chief Financial Officer,
        Secretary or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is
        issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.

       

      

      2.3.2.      Registered Holder.
          Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of
          such Warrant (notwithstanding any notation of ownership or other writing on any physical certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the
          Company nor the Warrant Agent shall be affected by any notice to the contrary.

       

      

      2.4.        Detachability of
              Warrants. The Common Stock and Public Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the Prospectus
          or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business (a “Business Day”),
          then on the immediately succeeding Business Day following such date, or earlier (the “Detachment Date”) with the consent of UBS Securities LLC and Cowen and Company, LLC, as representatives of the several underwriters, but in no event shall the
          Common Stock and the Public Warrants comprising the Units be separately traded until (A) the Company has filed (i) a Current Report on Form 8-K with the Commission containing an audited balance sheet reflecting the receipt by the Company of the
          gross proceeds of the Offering, including the proceeds received by the Company from the exercise by the underwriters of their right to purchase additional Units in the Offering (the “Over-allotment Option”), if the Over-allotment Option is exercised prior to the
          filing of the Current Report on Form 8-K, and (ii) a second or amended Current Report on Form 8-K to provide updated financial information to reflect the exercise of the underwriters’ Over-allotment Option, if the Over-allotment Option is
          exercised following the filing of the Current Report on Form 8-K pursuant to clause (i) above, and (B) the Company issues a press release announcing when such separate trading shall begin.

       

      

      
        -3-

        
          


      

      2.5.         No Fractional
              Warrants Other Than as Part of Units. The Company shall not issue fractional Warrants other than as part of the Units, each of which is comprised of one share of Common Stock and one-fifth of one Public Warrant. If, upon the detachment of Public Warrants from Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number
          the number of Warrants to be issued to such holder.

       

      

      2.6.        Private Placement
              Warrants; Working Capital Warrants. The Private Placement Warrants and the Working Capital Warrants shall be identical to the Public Warrants, except that so long as they are held by the Sponsor or any of its Permitted Transferees
          (as defined below), as applicable, the Private Placement Warrants and Working Capital Warrants: (i) may be exercised for cash or on a cashless basis, pursuant to subsection 3.3.1(b)
          hereof, (ii) may not be transferred, assigned or sold (including any shares of Common Stock issued upon exercise of the Private Placement Warrants or Working Capital Warrants) until thirty (30) days after the completion by the Company of an
          initial Business Combination (as defined below), and (iii) shall not be redeemable by the Company pursuant to Section 6.1 hereof; provided, however, that in the case of (ii), the Private Placement Warrants, Working Capital Warrants and any shares of Common Stock
          held by the Sponsor or any of its Permitted Transferees and issued upon exercise of the Private Placement Warrants or Working Capital Warrants may be transferred by the holders thereof:

       

      

    

    
      (a)          to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members of
        the Sponsor or any affiliates of the Sponsor, including to funds affiliated with Glenview Capital Management, LLC (“Glenview”), and to limited partners of funds affiliated with Glenview, provided that any such transfers to limited partners are made
        on a pro rata basis pursuant to the organizational documents of such funds;

       

      

      (b)          in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family or an
          affiliate of such person, or to a charitable organization;

       

      

      (c)          in the case of an individual, by virtue of laws of descent and distribution upon death of the individual;

       

      

      (d)          in the case of an individual, pursuant to a qualified domestic relations order;

       

      

      
        -4-

        
          


      

      (e)          by private sales or transfers made in connection with the consummation of
          the Company’s initial Business Combination at prices no greater than the price at which the Private Placement Warrants were originally purchased;

       

      

      (f)          in the event of the Company’s liquidation prior to the completion of its initial Business Combination;

       

      

      (g)          by virtue of the laws of the State of Delaware or the Sponsor’s limited liability company agreement, as amended, upon liquidation or dissolution of the Sponsor;

       

      

      (h)          in the event of the Company’s completion of a liquidation, merger, stock exchange, reorganization or other similar transaction which results in all of the Company’s public
          stockholders having the right to exchange their shares of Common Stock for cash, securities or other property subsequent to the completion of the Company’s initial Business
          Combination; or

       

      

      (i)           to the Company for no value for cancellation in connection with the consummation of the Company’s initial Business Combination

       

      

      provided, however, that in the case of clauses (a) through (e) or (g), these permitted transferees (the “Permitted Transferees”)
        must enter into a written agreement with the Company agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement between Company and its initial stockholders.

       

      

      2.7.         Working Capital
              Warrants. Each of the Working Capital Warrants shall be identical to the Private Placement Warrants.

       

      

      2.8.         Post-IPO
              Warrants. The Post-IPO Warrants, when and if issued, shall have the same terms and be in the same form as the Public Warrants, except as may be agreed upon by the Company.

       

      

      2.9.         Forward Purchase
              Warrants. Each of the Forward Purchase Warrants shall have the same terms and be in the same form as the Public Warrants.

       

      

      3.           Terms and Exercise of Warrants.

       

      

      3.1.         Warrant Price.
          Each whole Warrant shall, when countersigned by the Warrant Agent (if a physical certificate is issued), entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the
          number of shares of Common Stock stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used
          in this Agreement shall mean the price per share (including in cash or by payment of Warrants pursuant to a “cashless exercise,” to the extent permitted hereunder) at which shares of Common Stock may be purchased at the time a Warrant is
          exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days (unless otherwise required by the Commission, any
          national securities exchange on which the Warrants are listed or applicable law); provided, that the Company shall provide at least three (3) Business Days prior written notice of such reduction to Registered Holders of the Warrants and, provided
          further that any such reduction shall be identical among all of the Warrants.

       

      

      
        -5-

        
          


      

      3.2.         Duration of
              Warrants. A Warrant may be exercised only during the period (the “Exercise







            Period”) commencing on the date that is thirty (30) days after the first date on which the Company completes a merger, capital stock exchange, asset acquisition, stock
          purchase, reorganization or similar business combination, involving the Company and one or more businesses (a “Business Combination”), and terminating the earliest to occur of: (w) at 5:00 p.m., New York City time on the date that is five (5) years after
          the date on which the Company completes its Business Combination, (x) the liquidation of the Company, if the Company fails to complete a Business Combination, (y) other than with respect to the Private Placement Warrants and Working Capital
          Warrants then held by the Sponsor or any of its Permitted Transferees, with respect to a redemption pursuant to Section 6.1 hereof, at 5:00 p.m., New York City time on the
          Redemption Date (as defined below) as provided in Section 6.3 hereof, and (z) other than with respect to the Private Placement Warrants and Working Capital Warrants then
          held by the Sponsor or any of its Permitted Transferees (unless the last reported sale price of the Common Stock is less than $18.00 per share (subject to adjustment in compliance with Section







              4 hereof) for any 10 trading days within the 20-day Reference Period), with respect to a redemption pursuant to Section 6.2 hereof, at 5:00 p.m., New York
          City time on the Redemption Date as provided in Section 6.3 hereof (the “Expiration Date”); provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below with respect to an effective registration statement or a valid exemption therefrom being available. Except with respect to the right to receive the Redemption Price (as defined below) in
          the event of a redemption (as set forth in Section 6 hereof), each Warrant (other than a Private Placement Warrant or a Working Capital Warrant that may not be redeemed in
          connection with such event of redemption pursuant to the terms of this Agreement) not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at
          5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided
          that the Company shall provide at least twenty (20) days prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical in duration among all the Warrants.

    

    

    3.3.         Exercise of Warrants.

    

    

    3.3.1.     Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder thereof by
      delivering to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised, or, in the case of a Book-Entry Warrant Certificate, the Warrants to be exercised (the “Book-Entry Warrants”) on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by
      the Warrant Agent to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”) any shares of Common Stock pursuant
      to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the Definitive Warrant Certificate or, in the case of a Book-Entry Warrant Certificate, properly delivered by the Participant in accordance with
      the Depositary’s procedures, and (iii) payment in full of the Warrant Price for each full share of Common Stock as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of
      the Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

    

    

    
      -6-

      
        


    

    (a)          in lawful money of the United States, in good certified check or good bank draft payable to the order of the Warrant Agent;

    

    

    (b)          with respect to any Private Placement Warrant or Working Capital Warrant (other than an exercise in accordance with the terms of Section 6.2
      hereof), so long as such Private Placement Warrant or Working Capital Warrant is held by the Sponsor or a Permitted Transferee, by surrendering the Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the
      product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value,”
      as defined in this subsection 3.3.1(b), over the Warrant Price by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(b), the “Fair Market Value” shall mean the average last reported
      sale price of the shares of Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which notice of exercise of the Private Placement Warrant or Working Capital Warrant is sent to the Warrant Agent;

    

    

    (c)          as provided in Section 6.2 hereof with respect to a Make-Whole Exercise; or

    

    

    (d)          as provided in Section 7.4 hereof.

    

    

    3.3.2.     Issuance of Shares of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds
      in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of such Warrant a book-entry position or
      certificate, as applicable, for the number of full shares of Common Stock to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new
      book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any shares of
      Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock underlying the Public
      Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its obligations under Section 7.4, or a valid exemption from registration is available. No Warrant shall be exercisable and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless Common
      Stock issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants, except pursuant to Section 7.4. The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4 hereof. If, by reason of
      any exercise of Warrants on a “cashless basis,” the holder of any Warrant would be entitled, upon the exercise of such
      Warrant, to receive a fractional interest in a share of Common Stock, the Company shall round down to the nearest whole number, the number of shares of Common Stock to be issued to such holder.

    

    

    
      -7-

      
        


    

    3.3.3.     Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be
      validly issued, fully paid and non-assessable.

    

    

    3.3.4.     Date of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued
      shall for all purposes be deemed to have become the holder of record of such shares of Common Stock on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made,
      irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book-entry system of the Warrant Agent
      are closed, such person shall be deemed to have become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer books or book-entry system are open.

    

    

    3.3.5.     Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions
      contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as
      such holder may specify) (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such
      person and its affiliates shall include the number of shares of Common Stock issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would be issuable
      upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially
      owned by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set
      forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in
      determining the number of outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent
      Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the
      Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such
      holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and
      its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such
      holder to any other percentage specified in such notice; provided, however, that any such increase shall
      not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

    

    

    
      -8-

      
        


    

    4.           Adjustments.

    

    

    4.1.         Stock Dividends.

    

    

    4.1.1.     Split-Ups. If after the date hereof, and subject to the provisions of Section







          4.6 below, the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock or other similar event, then, on the effective date of such
      stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering to holders of the
      Common Stock entitling holders to purchase shares of Common Stock at a price less than the “Fair Market Value” (as
      defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such
      rights offering that are convertible into or exercisable for the Common Stock) and (ii) one (1) minus the quotient of (x) the price per share of Common Stock paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price payable for Common Stock, there shall be
      taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Fair Market Value” means the volume weighted average price of the Common Stock during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the
      applicable exchange or in the applicable market, regular way, without the right to receive such rights.

    

    

    4.1.2.     Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a
      distribution in cash, securities or other assets to all or substantially all of the holders of the Common Stock on account of such shares of Common Stock (or other shares of the Company’s
      capital stock into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the
      redemption rights of the holders of the Common Stock in connection with a proposed initial Business Combination, (d) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to allow
      redemption in connection with the Company’s initial Business Combination or to redeem 100% of Common Stock if the Company does not complete the Business Combination within 24 months from the closing of the Offering or any extended time that the
      Company has to consummate a Business Combination beyond 24 months as a result of a stockholder vote to amend the Company’s amended and restated certificate of incorporation or with respect to any other provision relating to the rights of holders of
      Common Stock or pre-initial Business Combination activity, or (e) in connection with the redemption of all of the Common Stock upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets
      upon its liquidation (any such non-excluded event being referred to herein as an “Extraordinary







        Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair
      market value (as determined by the Board, in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection







          4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions paid on the Common Stock during the 365-day
      period ending on the date of declaration of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4
      and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Warrant) to the extent it does not exceed $0.50 (being 5% of the offering
      price of the Units in the Offering). Solely for purposes of illustration, if the Company, at a time while the Warrants are outstanding and unexpired, pays a cash dividend of $0.35 per share and previously paid an aggregate of $0.40 of cash dividends
      and cash distributions on the shares of Common Stock during the 365-day period ending on the date of declaration of such $0.35 per share dividend, then the Warrant Price will be decreased, effectively immediately after the effective date of such
      $0.35 per share dividend, by $0.25 (the absolute value of the difference between $0.75 per share (the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period, including such $0.35 dividend) and $0.50 per
      share (the greater of (x) $0.50 per share and (y) the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period prior to such $0.35 dividend)).

    

    

    
      -9-

      
        


    

    4.2.         Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on
      the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding
      shares of Common Stock.

    

    

    4.3.         Adjustments in Exercise Price.

    

    

    4.3.1.     Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or







      Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the
      numerator of which shall be the number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable
      immediately thereafter.

    

    

    4.3.2.     If (x) the Company issues additional shares of Common Stock or securities convertible into or exercisable or exchangeable for shares of Common Stock
        for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock, with such issue price or effective issue price to be determined
        in good faith by the Board (and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any shares of Common Stock issued prior to the Offering and held by the Sponsor or such affiliates, as applicable, prior
        to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds
        from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of an initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions),
        and (z) the volume weighted average trading price of the Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates an initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price will be adjusted (to the nearest
        cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described in Section 6.1 and Section 6.2 shall be adjusted (to the nearest cent)
        to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described in Section 6.2 shall be adjusted (to the nearest cent) to be equal to the higher of the Market Value and
        the Newly Issued Price

    

    

    
      -10-

      
        


    

    4.4.         Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of
      Common Stock (other than a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into another entity or conversion of the Company as
      another entity (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or
      conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Warrants shall thereafter have the right
      to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights
      represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
      that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance” ); provided, however, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such
      consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per
      share by the holders of the Common Stock in such consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a
      tender, exchange or redemption offer made by the Company in connection with redemption rights held by stockholders of the Company as provided for in the Company’s amended and restated
      certificate of incorporation or as a result of the repurchase of shares of Common Stock by the Company if a proposed initial Business Combination is presented to the stockholders of the Company for approval) under circumstances in which, upon
      completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate
      or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule)) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3
      under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Common Stock, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to
      which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by such holder had
      been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided, further, that if less than 70% of the consideration receivable by the holders of Common Stock in the applicable event is payable in the form of common
        equity in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered
        Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be
        reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B) the Black-Scholes Warrant
        Value (as defined below). The “Black-Scholes Warrant Value” means the value of
        a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume weighted average price of the shares of Common Stock as reported during the ten (10)
        trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately
        prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the shares of Common Stock consists
        exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the amount of cash per share of Common Stock, if any, plus the volume weighted average price of the shares of Common Stock as reported during the
        ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be
      reduced to less than the par value per share issuable upon exercise of the Warrant.

    

    

    
      -11-

      
        


    

    4.5.         Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable upon
      exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of shares of Common Stock
      purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective
      date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

    

    

    4.6.         No Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue
      fractional shares of Common Stock upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled,
      upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

    

    

    4.7.         Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares of Common Stock as is stated in the Warrants initially issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of
      Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so
      changed.

    

    

    4.8.         Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections of this
      Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the Warrants and (ii) effectuate
      the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm
      of recognized national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment; provided, however, that under no circumstances shall the Warrants be adjusted pursuant to this Section 4.8 as a result of any issuance of securities in connection with a Business Combination. The Company shall adjust the terms of the Warrants in a manner that is consistent
      with any adjustment recommended in such opinion.

    

    

    4.9.         No Adjustment. For the avoidance of doubt, no adjustment shall be made to the terms of the Warrants solely as a result of an
      adjustment to the conversion ratio of the Class B common stock of the Company, par value $0.0001 per share (the “Class B Common Stock”), into shares of Common Stock or the conversion of the shares of Class B Common Stock into shares of Common Stock, in each
      case, pursuant to the Company’s amended and restated certificate of incorporation, as amended from time to time.

    

    

    
      -12-

      
        


    

    5.           Transfer and Exchange of Warrants.

    

    

    5.1.         Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the
      Warrant Register, upon surrender of such Warrant for transfer, in the case of certificated Warrants, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant
      representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the Company
      from time to time upon request.

    

    

    5.2.         Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or
      transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that except as otherwise provided herein or with respect to any Book-Entry Warrant, each Book-Entry Warrant
      may be transferred only in whole and only to the Depositary, to another nominee of the Depositary, to a successor depositary, or to a nominee of a successor depository; provided further,
      however that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants and the Working Capital Warrants),
      the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must
      also bear a restrictive legend.

    

    

    5.3.         Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in
      the issuance of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

    

    

    5.4.         Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

    

    

    5.5.          Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the
      terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant Agent, shall supply
      the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

    

    

    5.6.         Transfer of Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in
      which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the
      Warrants included in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after the Detachment
      Date.

    

    

    
      -13-

      
        


    

    6.           Redemption.

    

    

    6.1.         Redemption of Warrants for Cash. Subject to Section 6.5
      hereof, not less than all of the outstanding Public Warrants may be redeemed, at the option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as
      described in Section 6.3 below, at the price (the “Redemption Price”) of $0.01 per Public Warrant, provided that the last reported sales price of
      the Common Stock reported has been at least $18.00 per share (subject to adjustment in compliance with Section 4 hereof), on at least ten (10) trading days within the twenty
      (20) trading-day period commencing no earlier than the date the Public Warrants become exercisable and ending on the third Business Day prior to the date on which notice of the redemption is given (the “20-day Reference Period”), and provided that there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, and a current
      prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.3 below).

    

    

    6.2.         Redemption of Warrants for $0.10 or for Shares of Common Stock. Subject to Section







          6.5 hereof, not less than all of the outstanding Public Warrants may be redeemed, at the option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders of the
      Warrants, as described in Section 6.3 below, at a Redemption Price of $0.10 per Public Warrant, provided that the last reported sales price of the Common Stock has been at
      least $10.00 per share (subject to adjustment in compliance with Section 4 hereof), on at least ten (10) trading days within the 20-day Reference Period and, unless the last
      reported sales price of the Common Stock has been at least $18.00 per share (subject to adjustment in compliance with Section 4 hereof) on at least ten (10) trading days within
      the 20-day Reference Period, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. During the 30-day Redemption Period in connection with a redemption pursuant to this Section 6.2, Registered Holders of the Warrants may elect to exercise their Warrants on a “cashless basis” and receive a number of shares of Common Stock determined by reference to the table below, based on the Redemption Date (calculated for purposes of the table as the period to expiration
      of the Warrants) and the “Fair Market Value” (a “Make-Whole Exercise”). For purposes of this Section 6.2, the “Fair Market Value” shall mean the volume-weighted average price
      of the Common Stock during the ten (10) trading days immediately following the date on which the notice of redemption is sent to Registered Holders of the Warrants.

    

      	

            	 	
              ​

               

              Fair Market Value of Class A Common Stock

            	 
	
              Redemption Date

              (period to expiration of warrants)

            	 	
              ≤10.00

            	 	 	
              11.00

            	 	 	
              12.00

            	 	 	
              13.00

            	 	 	
              14.00

            	 	 	
              15.00

            	 	 	
              16.00

            	 	 	
              17.00

            	 	 	
              ≥18.00

            	 
	
              60 months

            	 	
              0.261

            	 	 	
              0.281

            	 	 	
              0.297

            	 	 	
              0.311

            	 	 	
              0.324

            	 	 	
              0.337

            	 	 	
              0.348

            	 	 	
              0.358

            	 	 	
              0.361

            	 
	
              57 months

            	 	
              0.257

            	 	 	
              0.277

            	 	 	
              0.294

            	 	 	
              0.310

            	 	 	
              0.324

            	 	 	
              0.337

            	 	 	
              0.348

            	 	 	
              0.358

            	 	 	
              0.361

            	 
	
              54 months

            	 	
              0.252

            	 	 	
              0.272

            	 	 	
              0.291

            	 	 	
              0.307

            	 	 	
              0.322

            	 	 	
              0.335

            	 	 	
              0.347

            	 	 	
              0.357

            	 	 	
              0.361

            	 
	
              51 months

            	 	
              0.246

            	 	 	
              0.268

            	 	 	
              0.287

            	 	 	
              0.304

            	 	 	
              0.320

            	 	 	
              0.333

            	 	 	
              0.346

            	 	 	
              0.357

            	 	 	
              0.361

            	 
	
              48 months

            	 	
              0.241

            	 	 	
              0.263

            	 	 	
              0.283

            	 	 	
              0.301

            	 	 	
              0.317

            	 	 	
              0.332

            	 	 	
              0.344

            	 	 	
              0.356

            	 	 	
              0.361

            	 
	
              45 months

            	 	
              0.235

            	 	 	
              0.258

            	 	 	
              0.279

            	 	 	
              0.298

            	 	 	
              0.315

            	 	 	
              0.330

            	 	 	
              0.343

            	 	 	
              0.356

            	 	 	
              0.361

            	 
	
              42 months

            	 	
              0.228

            	 	 	
              0.252

            	 	 	
              0.274

            	 	 	
              0.294

            	 	 	
              0.312

            	 	 	
              0.328

            	 	 	
              0.342

            	 	 	
              0.355

            	 	 	
              0.361

            	 
	
              39 months

            	 	
              0.221

            	 	 	
              0.246

            	 	 	
              0.269

            	 	 	
              0.290

            	 	 	
              0.309

            	 	 	
              0.325

            	 	 	
              0.340

            	 	 	
              0.354

            	 	 	
              0.361

            	 
	
              36 months

            	 	
              0.213

            	 	 	
              0.239

            	 	 	
              0.263

            	 	 	
              0.285

            	 	 	
              0.305

            	 	 	
              0.323

            	 	 	
              0.339

            	 	 	
              0.353

            	 	 	
              0.361

            	 


      

      

      
        -14-

        
          


      

      	
              33 months

            	 	
              0.205

            	 	 	
              0.232

            	 	 	
              0.257

            	 	 	
              0.280

            	 	 	
              0.301

            	 	 	
              0.320

            	 	 	
              0.337

            	 	 	
              0.352

            	 	 	
              0.361

            	 
	
              30 months

            	 	
              0.196

            	 	 	
              0.224

            	 	 	
              0.250

            	 	 	
              0.274

            	 	 	
              0.297

            	 	 	
              0.316

            	 	 	
              0.335

            	 	 	
              0.351

            	 	 	
              0.361

            	 
	
              27 months

            	 	
              0.185

            	 	 	
              0.214

            	 	 	
              0.242

            	 	 	
              0.268

            	 	 	
              0.291

            	 	 	
              0.313

            	 	 	
              0.332

            	 	 	
              0.350

            	 	 	
              0.361

            	 
	
              24 months

            	 	
              0.173

            	 	 	
              0.204

            	 	 	
              0.233

            	 	 	
              0.260

            	 	 	
              0.285

            	 	 	
              0.308

            	 	 	
              0.329

            	 	 	
              0.348

            	 	 	
              0.361

            	 
	
              21 months

            	 	
              0.161

            	 	 	
              0.193

            	 	 	
              0.223

            	 	 	
              0.252

            	 	 	
              0.279

            	 	 	
              0.304

            	 	 	
              0.326

            	 	 	
              0.347

            	 	 	
              0.361

            	 
	
              18 months

            	 	
              0.146

            	 	 	
              0.179

            	 	 	
              0.211

            	 	 	
              0.242

            	 	 	
              0.271

            	 	 	
              0.298

            	 	 	
              0.322

            	 	 	
              0.345

            	 	 	
              0.361

            	 
	
              15 months

            	 	
              0.130

            	 	 	
              0.164

            	 	 	
              0.197

            	 	 	
              0.230

            	 	 	
              0.262

            	 	 	
              0.291

            	 	 	
              0.317

            	 	 	
              0.342

            	 	 	
              0.361

            	 
	
              12 months

            	 	
              0.111

            	 	 	
              0.146

            	 	 	
              0.181

            	 	 	
              0.216

            	 	 	
              0.250

            	 	 	
              0.282

            	 	 	
              0.312

            	 	 	
              0.339

            	 	 	
              0.361

            	 
	
              9 months

            	 	
              0.090

            	 	 	
              0.125

            	 	 	
              0.162

            	 	 	
              0.199

            	 	 	
              0.237

            	 	 	
              0.272

            	 	 	
              0.305

            	 	 	
              0.336

            	 	 	
              0.361

            	 
	
              6 months

            	 	
              0.065

            	 	 	
              0.099

            	 	 	
              0.137

            	 	 	
              0.178

            	 	 	
              0.219

            	 	 	
              0.259

            	 	 	
              0.296

            	 	 	
              0.331

            	 	 	
              0.361

            	 
	
              3 months

            	 	
              0.034

            	 	 	
              0.065

            	 	 	
              0.104

            	 	 	
              0.150

            	 	 	
              0.197

            	 	 	
              0.243

            	 	 	
              0.286

            	 	 	
              0.326

            	 	 	
              0.361​

            	 
	
              0 months

            	 	
              -

            	 	 	
              -

            	 	 	
              0.042

            	 	 	
              0.115

            	 	 	
              0.179

            	 	 	
              0.233

            	 	 	
              0.281

            	 	 	
              0.323

            	 	 	
              ​0.361

            	 


    

    

    The exact Fair Market Value and Redemption Date (as defined below) may not be set forth in the table above, in which case, if the Fair Market Value is between two values in the table or the Redemption Date is between two
      redemption dates in the table, the number of shares of Common Stock to be issued for each Warrant exercised in a Make-Whole Exercise will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower
      Fair Market Values and the earlier and later redemption dates, as applicable, based on a 365- or 366-day year, as applicable.

    

    

    The share prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable upon exercise of a Warrant or the Exercise Price is adjusted pursuant to Section 4 hereof. If the number of shares issuable upon exercise of a Warrant is adjusted pursuant to Section 4 hereof, the adjusted share prices in the column headings shall equal
      the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the exercise price of the warrant after such adjustment and the denominator of which is the exercise price of the warrant immediately prior to
      such adjustment. In such an event, the number of shares in the table above shall be adjusted by multiplying such share amounts by a fraction, the numerator of which is the number of shares deliverable upon exercise of a Warrant immediately prior to
      such adjustment and the denominator of which is the number of shares deliverable upon exercise of a Warrant as so adjusted. If the Exercise Price is adjusted, (a) in the case of an adjustment pursuant to Section 4.4 hereof, the adjusted share prices
      in the column headings shall equal the share prices immediately prior to such adjustment multiplied by a fraction, the numerator of which is the higher of the Market Value and the Newly Issued Price and the denominator of which is $10.00 and (b) in
      the case of an adjustment pursuant to Section 4.1.2 hereof, the adjusted share prices in the column headings shall equal the share prices immediately prior to such adjustment
      less the decrease in the Exercise Price pursuant to such Exercise Price adjustment. In no event shall the number of shares issued in connection with a Make-Whole Exercise exceed 0.361 shares of Common Stock per Warrant (subject to adjustment).

    

    

    
      -15-

      
        


    

    6.3.         Date Fixed for, and Notice of, Redemption. In the event that the Company elects to redeem all of the Warrants pursuant to Sections 6.1 or 6.2, the Company shall fix a
      date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the “30-day Redemption Period”) to the Registered
      Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the Registered Holder
      received such notice.

    

    

    6.4.         Exercise After Notice of Redemption. The Warrants may be exercised, for cash (or on a “cashless basis” in accordance with Section 6.2 of this Agreement) at any time
      after notice of redemption shall have been given by the Company pursuant to Section 6.3 hereof and prior to the Redemption Date. On and after the Redemption Date the record
      holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption Price.

    

    

    6.5.        Exclusion of Private Placement Warrants. The Company agrees that the redemption rights provided in Section 6.1 and Section 6.2 (if the last reported sale price of the Common Stock has been at least $18.00 per share (subject to
      adjustment in compliance with Section 4 hereof) for any 10 trading days within the 20-day Reference Period) shall not apply to the Private Placement Warrants, the Working
      Capital Warrants or the Post-IPO Warrants (if such Post-IPO Warrants provide that they are non-redeemable by the Company for cash) if at the time of the redemption such Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants
      continue to be held by the Sponsor or its Permitted Transferees. However, once such Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants are transferred (other
      than to Permitted Transferees in accordance with Section 2.5), the Company may redeem the Private Placement Warrants, Working Capital Warrants or the Post-IPO Warrants pursuant
      to Section 6.1 hereof, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement Warrants, Working Capital Warrants or
      Post-IPO Warrants to exercise the Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants prior to redemption pursuant to Section 6.4. The Private Placement
      Warrants, the Working Capital Warrants or the Post-IPO Warrants (if such Post-IPO Warrants provide that they are non-redeemable by the Company) that are transferred to persons other than Permitted Transferees shall upon such transfer cease to be
      Private Placement Warrants, Working Capital Warrants or Post-IPO Warrants and shall become Public Warrants under this Agreement.

    

    

    7.           Other Provisions Relating to Rights of Holders of Warrants.

    

    

    7.1.         No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the
      Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of
      directors of the Company or any other matter.

    

    

    7.2.         Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant
      Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so
      lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

    

    

    
      -16-

      
        


    

    7.3.         Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares
      of Common Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

    

    

    7.4.         Registration of Common Stock; Cashless Exercise at Company’s Option.

    

    

    7.4.1.     Registration of the Common Stock. The Company agrees that as soon as practicable, but in no event later than fifteen (15) Business Days
      after the closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a post-effective amendment to the Registration Statement or a new registration statement for the registration, under
      the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall use its commercially reasonable efforts to cause the same to become effective within sixty (60) Business Days following the closing of its
      initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of this Agreement. If any
      such registration statement has not been declared effective by the 60th Business Day following the closing of the Business Combination, holders of the applicable Warrants shall have the right, during the period beginning on the 61th Business Day
      after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an effective registration statement
      covering the issuance of the shares of Common Stock issuable upon exercise of the applicable Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any
      successor rule) or another exemption) for that number of shares of Common Stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of
      the “Fair Market Value” (as defined below) over the Warrant Price by (y) the Fair Market Value and (B) 0.361 per whole Warrant (subject to adjustment). Solely for purposes of this subsection







          7.4.1, “Fair Market Value” shall mean the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the
      Warrant Agent from the holder of such Warrants or his, her or its securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with
      the “cashless exercise” of a Public Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of
      the Warrants on a cashless basis in accordance with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued
      upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act (or any successor statute)) of the Company and, accordingly, shall
      not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the avoidance of any doubt, unless and until all of the Warrants have been exercised or
      have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

    

    

    
      -17-

      
        


    

    7.4.2.     Cashless Exercise at Company’s Option. If the shares of Common Stock are at the time of any exercise of a Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under
      Section 18(b)(1) of the Securities Act, the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities
      Act as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the shares of Common
      Stock issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its commercially reasonable efforts to register or qualify for sale the shares of Common Stock issuable upon exercise of the Public
      Warrant under applicable blue sky laws to the extent an exemption is not available.

    

    

    8.           Concerning the Warrant Agent and Other Matters.

    

    

    8.1.         Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the
      Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares of Common Stock.

    

    

    8.2.         Resignation, Consolidation, or Merger of Warrant Agent.

    

    

    8.2.1.     Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be
      discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by
      resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been
      notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit such holder’s Warrant for inspection by the Company), then the holder of any Warrant may apply to the
      Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed
      by the Company or by such court, shall be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and authorized under
      such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and
      obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute
      and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company
      shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

    

    

    
      -18-

      
        


    

    8.2.2.     Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to
      the predecessor Warrant Agent and the Transfer Agent for the Common Stock not later than the effective date of any such appointment.

    

    

    8.2.3.     Merger or Consolidation of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or
      any corporation resulting from any merger or entity to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further act.

    

    

    8.3.          Fees and Expenses of Warrant Agent.

    

    

    8.3.1.     Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and
      shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

    

    

    8.3.2.     Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged,
      and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.

    

    

    8.4.         Liability of Warrant Agent.

    

    

    8.4.1.     Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary
      or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be
      conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, Secretary or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement
      for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

    

    

    8.4.2.     Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct, fraud or bad faith. The
      Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket costs and reasonable outside counsel fees, for anything done or omitted by the Warrant Agent in the execution of
      this Agreement, except as a result of the Warrant Agent’s gross negligence, willful misconduct, fraud or bad faith.

    

    

    
      -19-

      
        


    

    8.4.3.      Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the
      validity or execution of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall
      not be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the
      ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued
      pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall, when issued, be valid and fully paid and non-assessable.

    

    

    8.5.         Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon
      the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase
      of shares of Common Stock through the exercise of the Warrants.

    

    

    8.6.         Waiver. The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution of,
      the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and the Warrant Agent, as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment
      or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

    

    

    9.           Miscellaneous Provisions.

    

    

    9.1.         Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind
      and inure to the benefit of their respective successors and assigns.

    

    

    9.2.         Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any
      Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until
      another address is filed in writing by the Company with the Warrant Agent), as follows:

    

    

    Longview Acquisition Corp. II

    767 Fifth Avenue, 44th Floor

    New York, NY 10153

    Attention: Mark Horowitz

    

    

    Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by
      certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

    

    

    
      -20-

      
        


    

    Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, NY 10004

    Attention: Compliance Department

    

    

    With a copy in each case to:

    Ropes & Gray LLP

    1211 Avenue of the Americas

    New York, New York 10036

    
      
        
          
            Attn:   Paul D. Tropp

          

        

      

    

    Christopher J. Capuzzi

    

    

    and

    

    

    Skadden, Arps, Slate, Meagher & Flom LLP

    300 South Grand Avenue, Suite 3400

    Los Angeles, California 90071

    Attn:   Gregg A. Noel

    Michael J. Mies

    

    

    and

    

    

    UBS Securities LLC

    1285 Avenues of the Americas

    New York, New York 10019

    Attn:   Syndicate

    

    

    and

    

    

    Cowen and Company, LLC

    599 Lexington Avenue

    New York, NY 10022

    Attn:   Head of Equity Capital Markets, with a copy to the General Counsel Investment Banking

    

    

    9.3.         Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be
      governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The Company hereby agrees that any action,
      proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably
      submits to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such jurisdiction and that such courts represent an inconvenient forum. Notwithstanding
      the foregoing, the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and
      exclusive forum.

    

    

    

    
      -21-

      
        


    

    Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3. If any action, the subject matter
      of which is within the scope of the forum provisions above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any
      warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States District Court for the Southern District of New York in
      connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s
      counsel in the foreign action as agent for such warrant holder.

    

    

    9.4.         Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person,
      corporation or other entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All
      covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants.

    

    

    9.5.         Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant
      Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to submit such holder’s Warrant for inspection by it.

    

    

    9.6.         Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall
      for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission shall be
      deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

    

    

    9.7.         Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the
      interpretation thereof.

    

    

    
      -22-

      
        


    

    9.8.         Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder (i) for the purpose of
      curing any ambiguity or to correct any mistake, including to conform to the provisions hereof to the description of the terms of the Warrants and this Agreement set forth in the Prospectus, or curing, correcting or supplementing any defective
      provision contained herein or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest
      of the Registered Holders, and (ii) to provide for the delivery of Alternative Issuance pursuant to Section 4.4. All other modifications or amendments, including any amendment
      to increase the Warrant Price or shorten the Exercise Period, shall require the vote or written consent of the Registered Holders of 50% of the then outstanding Public Warrants and, solely with respect to any amendment to the terms of the Private
      Placement Warrants or Working Capital Warrants or any provision of this Agreement with respect to the Private Placement Warrants or Working Capital Warrants, 50% of the number of then-outstanding Private Placement Warrants and Working Capital
      Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the Registered Holders. Notwithstanding anything to the contrary herein, after
        the issuance of the Forward Purchase Warrants and prior to the effectiveness of a registration statement covering the resale of the Forward Purchase Warrants and the Common Stock underlying such Forward Purchase Warrants, any modification or
        amendment to the terms of the Forward Purchase Warrants shall require the vote or written consent of the Registered Holders of 50% of the number of the then outstanding Forward Purchase Warrants.  Upon effectiveness of the registration statement
        covering the resale of the Forward Purchase Warrants and the Common Stock underlying such Forward Purchase Warrants, the Public Warrants and Forward Purchase Warrants will vote together as a single class on all matters submitted to a vote of the
        holders of the Warrants.

    

    

    9.9.         Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall
      not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this
      Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

    

    

    Exhibit A  Form of Warrant Certificate

    Exhibit B  Legend – Private Placement Warrants

     

      

    
      -23-

      
        


    

    IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

     

    

    	 	
            LONGVIEW ACQUISITION CORP. II

          
	 	 	 
	 	
            By:

          	

          
	 	
            Name:

          	 
	 	
            Title:

          	 
	 	 	 
	 	
            CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

          
	 	 	 
	 	
            By:

          	

          
	 	
            Name:

          	 
	 	
            Title:

          	 


    

    

    
      
        


    

    
    EXHIBIT A

    

    

    Form of Warrant Certificate

    

    

    [FACE]

    

    

    Number

    

    

    Warrants

    

    

    THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO

    THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

    IN THE WARRANT AGREEMENT DESCRIBED BELOW

    

    

    LONGVIEW ACQUISITION CORP. II

    Incorporated Under the Laws of the State of Delaware

    

    

    CUSIP [__________]

    

    

    Warrant Certificate

    

    

    This Warrant Certificate certifies that                      , or registered assigns, is the registered holder of warrant(s) evidenced hereby (the “Warrants” and each,
      a “Warrant”) to
      purchase shares of Class A common stock, $0.0001 par value per share (“Common Stock”), of Longview Acquisition Corp. II, a Delaware corporation (the “Company”). Each Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to
      receive from the Company that number of fully paid and non-assessable shares of Common Stock as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful money (or through “cashless exercise”
      as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth
      herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

    

    

    Each whole Warrant is initially exercisable for one fully paid and non-assessable share of Common Stock. The number of shares of Common Stock issuable upon exercise of the Warrants is subject to adjustment upon the
      occurrence of certain events set forth in the Warrant Agreement.

    

    

    The initial Exercise Price per share of Common Stock for any Warrant is equal to $11.50 per share. If, upon the exercise of Warrants, a holder would be entitled to receive a fractional interest in a share of Common
      Stock, the Company will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the Warrant holder. The Exercise Price is subject to adjustment upon the occurrence of certain events set forth in the
      Warrant Agreement.

    

    

    Subject to the conditions set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such Warrants shall become
      void. The Warrants may be redeemed, subject to certain conditions, as set forth in the Warrant Agreement.

    

    

    
      A-1

      
        


    

    Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as though fully set forth at this
      place.

    

    

    This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

    

    

    This Warrant Certificate shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof.

     

    

    	 	
            LONGVIEW ACQUISITION CORP. II

          
	 	 	 
	 	
            By:

          	

          
	 	
            Name:

          	 
	 	
            Title:

          	 
	 	 	 
	 	
            CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

          
	 	 	 
	 	
            By:

          	

          
	 	
            Name:

          	 
	 	
            Title:

          	 


    

    

    
      A-2

      
        


    

    Form of Warrant Certificate

    

    

    [Reverse]

    

    

    The Warrants evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive shares of Common Stock and are issued or to be issued pursuant to a Warrant
      Agreement dated as of [_____________], 2021 (the “Warrant Agreement”), duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby
      incorporated by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the
      words “holders”
      or “holder”
      meaning the Registered Holders or Registered Holder) of the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein
      shall have the meanings given to them in the Warrant Agreement.

    

    

    Warrants may be exercised at any time during the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this Warrant
      Certificate, with the form of election to purchase set forth hereon properly completed and executed, together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any
      exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the
      number of Warrants not exercised.

    

    

    Notwithstanding anything else in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the shares of Common Stock to be issued
      upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating to the shares of Common Stock is current, except through “cashless exercise” as provided for in the Warrant Agreement.

    

    

    The Warrant Agreement provides that upon the occurrence of certain events the number of shares of Common Stock issuable upon exercise of the Warrants set forth on the face hereof may, subject to certain conditions, be
      adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest in a share of Common Stock, the Company shall, upon exercise, round down to the nearest whole number of shares of Common Stock to be
      issued to the holder of the Warrant.

    

    

    Warrant Certificates, when surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney duly authorized in writing, may be
      exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of
      Warrants.

    

    

    Upon due presentation for registration of transfer of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like
      number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection
      therewith.

    

    

    
      A-3

      
        


    

    The Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by
      anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Warrants nor this
      Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

    

    

    
      A-4

      
        


    

    Election to Purchase

    

    

    (To Be Executed Upon Exercise of Warrant)

    

    

    The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive shares of Common Stock and herewith tenders payment for such shares of Common Stock to the order of
      Longview Acquisition Corp. II (the “Company”) in the amount of $          in accordance with the terms hereof. The undersigned requests that a certificate for such
      shares of Common Stock be registered in the name of             , whose address is and that such shares of Common Stock be delivered to whose address is            . If said number of shares of Common Stock is less than all of the shares of Common
      Stock purchasable hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of              , whose address is and that such Warrant Certificate be
      delivered to            , whose address is         .

    

    

    In the event that the Warrant has been called for redemption by the Company pursuant to Section 6.2 of the Warrant Agreement and a holder thereof
      elects to exercise its Warrant pursuant to a Make-Whole Exercise, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with Section
          6.2 of the Warrant Agreement.

    

    

    In the event that the Warrant is a Private Placement Warrant or a Working Capital Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(b) of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable
      for shall be determined in accordance with subsection 3.3.1(b) of the Warrant Agreement.

    

    

    In the event that the Warrant is to be exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

    

    

    In the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of shares of Common Stock that this Warrant is exercisable for would be determined
      in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right, represented by this
      Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive shares of Common Stock. If said number of shares is less than all of the shares of Common Stock purchasable hereunder (after giving effect to the
      cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of                , whose address is and that such Warrant Certificate be
      delivered to                , whose address is                  .

    

    

    [Signature Page Follows]

    

    

    
      A-5

      
        


    

    	
            Date:                 , 2021

          	

          
	 	
            (Signature)

          
	 	 
	 	

          
	 	 
	 	 
	 	
            (Address)

          
	 	 
	 	

          
	 	
            (Tax Identification Number)

          


    

    

    Signature Guaranteed:

    

    

    THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15
      (OR ANY SUCCESSOR RULE)).

    

    

    
      A-6

      
        


    

    EXHIBIT B

    

    

    LEGEND

    

    

    “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG LONGVIEW
      ACQUISITION CORP. II (THE “COMPANY”), LONGVIEW INVESTORS II LLC AND THE OTHER PARTIES THERETO, THE SECURITIES
      REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED TO
      HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.  SECURITIES EVIDENCED BY THIS CERTIFICATE AND SHARES OF CLASS A COMMON STOCK
      OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED BY THE COMPANY.”

    

    

    
      	
              No.

            	
              Warrants

            


    

    

    

    

    

    B-1